FAM171B and digestive system neoplasm: Beyond its implications in bladder cancer, FAM171B seems to exert substantial immunomodulatory effects in digestive tumors, including colon adenocarcinoma, liver hepatocellular carcinoma, and pancreatic adenocarcinoma.